Faculty of Pharmacy, Universitas 17 Agustus 1945, Jakarta, 14350, Indonesia.
Medicinal Plant and Traditional Medicine Research and Development Center, Jl. Raya Lawu 11, Tawangmangu, Karanganyar, Central Java, 57792, Indonesia.
J Ethnopharmacol. 2021 Oct 5;278:114316. doi: 10.1016/j.jep.2021.114316. Epub 2021 Jun 8.
The genus Pterocarpus (Fabaceae) has about 46 species that are distributed over Asia, especially Indonesia, Africa, and several countries in America. Particularly, P. indicus and P. santalinus have been recorded as ancestor recipe in the old Indonesian book (Cabe puyang warisan nenek moyang). These plants have found application in traditional medicine, such as in the treatment of inflammatory diseases, gonorrhoea, infection, coughs, mouth ulcers, boils, diarrhoea, as well as in the management of pain (as an analgesic).
The present review aimed to comprehensively summarise the current researches on the traditional and scientific applications of the genus Pterocarpus with regard to the phytochemical content, in vivo and in vitro bioactivities, as well as clinical evidence that may be useful for future drug development.
Information about the Pterocarpus genus were obtained from local classic herbal literature and electronic databases, such as PubMed, Scopus, and Google Scholar. The scientific name of the species and its synonyms were checked with the information of The Plant List. Additionally, clinical trial results were obtained from the Cochrane library.
Several phytochemical constituents of the plants, e.g., flavonoids, isoflavonoids, terpenoids, phenolic acids, and fatty acids have been reported. There are about 11 species of Pterocarpus that have been scientifically studied for their biological activities, including anti-inflammatory, anti-microbial, analgesic, and anti-hyperglycemic. Of which, the anti-hyperglycemic activity of the extracts and phytochemicals of P. indicus and P. marsupium is particularly remarkable, allowing them to be further studied under clinical trial.
The present review has provided an insight into the traditional applications of the plants and some of them have been validated by scientific evidence, particularly their applications as anti-inflammatory and anti-microbial agents. In addition, the genus has demonstrated notable anti-diabetic activity in various clinical trials.
紫檀属(豆科)约有 46 种,分布于亚洲,特别是印度尼西亚、非洲和美洲的几个国家。特别是,印度紫檀和紫檀已被记录为古印度尼西亚书籍(Cabe puyang warisan nenek moyang)中的祖先配方。这些植物在传统医学中得到了应用,例如治疗炎症性疾病、淋病、感染、咳嗽、口腔溃疡、痈、腹泻以及疼痛管理(作为镇痛药)。
本综述旨在全面总结紫檀属植物的传统和科学应用,包括植物化学物质、体内和体外生物活性以及可能有助于未来药物开发的临床证据。
从当地经典草药文献和电子数据库(如 PubMed、Scopus 和 Google Scholar)中获取有关紫檀属的信息。通过 The Plant List 检查物种及其同义词的学名。此外,从 Cochrane 图书馆获得临床试验结果。
已报道了植物的几种植物化学物质成分,例如类黄酮、异黄酮、萜类、酚酸和脂肪酸。约有 11 种紫檀属植物已在科学上研究了其生物活性,包括抗炎、抗菌、镇痛和抗高血糖。其中,印度紫檀和紫檀提取物和植物化学物质的抗高血糖活性尤为显著,允许它们在临床试验中进一步研究。
本综述提供了对植物传统应用的深入了解,其中一些已通过科学证据得到验证,特别是它们作为抗炎和抗菌剂的应用。此外,该属在各种临床试验中表现出显著的抗糖尿病活性。